Literature DB >> 15879580

Expression of components of the renin-angiotensin system in autosomal recessive polycystic kidney disease.

Mahmoud Loghman-Adham1, Carlos E Soto, Tadashi Inagami, Cirilo Sotelo-Avila.   

Abstract

Hypertension is a common complication in children with autosomal recessive polycystic kidney disease (ARPKD) who have survived the neonatal period. No information is available regarding the mechanism of hypertension in this condition. The renin-angiotensin system (RAS) is thought to play a role in hypertension associated with the more common autosomal dominant polycystic kidney disease (ADPKD). Occasional reports have documented increased activity of the intrarenal RAS in ADPKD, with ectopic renin expression within cysts and dilated tubules. Because of similarities between ARPKD and ADPKD, we hypothesized that increased intrarenal RAS activity might also be found in ARPKD. We performed immunohistochemical studies on kidney tissues from two infants with ARPKD and two control kidneys. The cystic dilated tubules showed staining with the peanut lectin arachis hypogaea, a marker of distal tubules and collecting ducts, but not with lotus tetragonolobus, a marker of proximal tubules. Strong renin staining was seen in many cysts and tubules of ARPKD kidneys, but only in the afferent arterioles of the normal control kidneys. Angiotensinogen staining was also observed in some cysts and in proximal tubules. Staining for angiotensin-converting enzyme, angiotensin II type 1 receptor, and angiotensin II peptide was present in many cystic dilated tubules. These immunohistochemical studies document for the first time ectopic expression of components of the RAS in cystic-dilated tubules of ARPKD and suggest that overactivity of RAS could result in increased intrarenal angiotensin II production, which may contribute to the development of hypertension in ARPKD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879580     DOI: 10.1369/jhc.4A6494.2005

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  16 in total

1.  Role of genetic modifiers in an orthologous rat model of ARPKD.

Authors:  Caitlin C O'Meara; Matthew Hoffman; William E Sweeney; Shirng-Wern Tsaih; Bing Xiao; Howard J Jacob; Ellis D Avner; Carol Moreno
Journal:  Physiol Genomics       Date:  2012-06-05       Impact factor: 3.107

2.  Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference.

Authors:  Meral Gunay-Aygun; Ellis D Avner; Robert L Bacallao; Peter L Choyke; Joseph T Flynn; Gregory G Germino; Lisa Guay-Woodford; Peter Harris; Theo Heller; Julie Ingelfinger; Frederick Kaskel; Robert Kleta; Nicholas F LaRusso; Parvathi Mohan; Gregory J Pazour; Benjamin L Shneider; Vicente E Torres; Patricia Wilson; Colleen Zak; Jing Zhou; William A Gahl
Journal:  J Pediatr       Date:  2006-08       Impact factor: 4.406

Review 3.  Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease.

Authors:  Jessica Wen
Journal:  Clin Transl Sci       Date:  2011-12-07       Impact factor: 4.689

4.  The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.

Authors:  Miwa Goto; Nita Hoxha; Rania Osman; Katherine Macrae Dell
Journal:  Pediatr Nephrol       Date:  2010-08-27       Impact factor: 3.714

Review 5.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

6.  Comparison of the transduction efficiency of tyrosine-mutant adeno-associated virus serotype vectors in kidney.

Authors:  Yan F Qi; Qiu H Li; Vinayak Shenoy; Michael Zingler; Joo Y Jun; Amrisha Verma; Michael J Katovich; Mohan K Raizada
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-01       Impact factor: 2.557

7.  Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference.

Authors:  Lisa M Guay-Woodford; John J Bissler; Michael C Braun; Detlef Bockenhauer; Melissa A Cadnapaphornchai; Katherine M Dell; Larissa Kerecuk; Max C Liebau; Maria H Alonso-Peclet; Benjamin Shneider; Sukru Emre; Theo Heller; Binita M Kamath; Karen F Murray; Kenneth Moise; Eric E Eichenwald; Jacquelyn Evans; Roberta L Keller; Louise Wilkins-Haug; Carsten Bergmann; Meral Gunay-Aygun; Stephen R Hooper; Kristina K Hardy; Erum A Hartung; Randi Streisand; Ronald Perrone; Marva Moxey-Mims
Journal:  J Pediatr       Date:  2014-07-09       Impact factor: 4.406

8.  Paradoxical increase in blood pressure following bilateral native nephrectomy.

Authors:  Balgees A Ajlan; Osama Y Safdar; Mohammed Shalabi; Jameela A Kari
Journal:  Clin Case Rep       Date:  2015-05-18

9.  Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease.

Authors:  Takamitsu Saigusa; Yujing Dang; Marlene A Bunni; May Y Amria; Stacy L Steele; Wayne R Fitzgibbon; P Darwin Bell
Journal:  Physiol Rep       Date:  2015-05

10.  Renal denervation does not affect hypertension or the renin-angiotensin system in a rodent model of juvenile-onset polycystic kidney disease: clinical implications.

Authors:  Sheran Li; Cara M Hildreth; Ahmed A Rahman; Sean A Barton; Benjamin F Wyse; Chai K Lim; Paul M Pilowsky; Jacqueline K Phillips
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.